FDA Drug Application (076822) for RABEPRAZOLE SODIUM by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number076822
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRABEPRAZOLE SODIUM
Active IngredientRABEPRAZOLE SODIUM

Active IngredientCount
List of drugs with Active Ingredient RABEPRAZOLE SODIUM3


Back to FDA Applications sponsored by TEVA PHARMS USA